prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumA, Final Pathologic Diagnosis: A. Lymph node, sentinel node #1, excision: No carcinoma (0/1). B. Lymph node, sentinel node #2, excision: No carcinoma (0/1). C. Breast, left, partial mastectomy: 1. Invasive ductal carcinoma, SBR grade 2, 2.1 cm; see comment. 2. Ductal carcinoma in situ, solid and micropapillary types, 1 cm; see. comment. 3. Lobular carcinoma in situ, classic type; see comment. 4. Atypical ductal hyperplasia involving fibroadenoma. Note: Breast Tumor Synoptic Comment. - Laterality: Left. - Invasive tumor type: Invasive ductal carcinoma. - Invasive tumor size: 2.1 cm maximum diameter. - Invasive tumor grade (modified Bloom-Richardson): 2. Nuclear grade: 2, 2 points. Mitotic count: <10 mitotic figures/10 HPF, 1 point. Tubule/papilla formation: Definite tubule formation in <10%, 3 points. Total points and overall grade = 6,7 points = grade 2. - Lymphatic-vascular invasion: Present (Slide C11). - Resection margins for invasive tumor: - Deep margin: Negative; tumor is 3 mm away, on Slide C5. - Medial margin: Negative; tumor is 5 mm away, on Slide C11. - Lateral margin: Negative (widely clear, >1 cm). - Anterior/superior margin: Negative; tumor is 6 mm away, on Slide C10. - Anterior/inferior margin: Negative (tumor is widely clear, >1 cm). Ductal carcinoma in situ (DCIS) type: Solid-micropapillary. - Ductal carcinoma in situ size: Working Draft. DCIS present in contiguous sections, 1 cm maximum diameter (Slide C10). Ductal carcinoma in situ nuclear grade: Intermediate grade. - Necrosis in DCIS: Comedonecrosis, focal (<1/3). - Microcalcifications: None. - Resection margins for ductal carcinoma in situ: - Deep margin: Negative; tumor is <1 mm away, on Slide C13. - Medial margin: Negative; tumor is 1 mm away, on Slide C13. - Lateral margin: Negative (widely clear, >1 cm). - Anterior/superior margin: Negative; tumor is <1 mm away, on Slide C13. - Anterior/inferior margin: Negative (widely clear, >1 cm). - Lobular carcinoma in situ (LCIS): Present. - Number of lobules involved: Few. Nuclear type/size: Classic, small cell type. - Lymph node status: - Number of positive lymph nodes: 0. - Total number sampled: 2. - AJCC/UICC stage: pT2N0(S)MX. - Nontumorous breast tissue: Atypical ductal hyperplasia involving fibroadenoma. In Slide C11, a few lobules show round shaped nucleated cells with powdery blue vesicular cytoplasm. proliferating within lobule lumens. Immunohistochemistry for E cadherin is obtained and is necessary. to evaluate these cells. The stain is negative in these areas and supports the diagnosis of lobular. carcinoma in situ. An immunohistochemical test for estrogen and progesterone receptors was performed on block C5 and. C10. The test for estrogen receptors is negative. There is no nuclear staining in any tumor cells. Internal. positive control is positive. The test for progesterone receptors is positive. There is strong nuclear staining in >95% of tumor. cells. Internal positive control is present. Result of HER2/neu test: This carcinoma is indeterminate for HER2/neu oncoprotein over-expression. An immunohistochemical assay was performed on block C5 using the CB11 monoclonal antibody to. HER2/neu oncoprotein. The staining intensity of this carcinoma was 2 on a scale of 0-3. Carcinomas with staining Intensity scores of 0 or 1 are considered negative for over-expression of HER2/neu oncoprotein. Those with a staining intensity score of 2 are considered indeterminate. We and others have observed that many carcinomas with. staining intensity scores of 2 do not show gene amplification. All carcinomas with staining intensity scores of 2 are therefore. submitted for FISH testing. The results of the FISH test are issued directly from the molecular cytogenetics laboratory. Carcinomas with staining intensity scores of 3 are considered positive for over-expression of HER2/neu oncoprotein. Tumors in. this category show an excellent correlation between the results of immunohistochemical and FISH testing, and almost always show. gene amplification. Intraoperative Consult Diagnosis. FS1 (A) Left axillary SLN #1, biopsy: No carcinoma in one lymph node (0/1). (Dr. FS2 (B) Left axillary SLN #2, biopsy: No carcinoma in one lymph node (0/1). (Dr. Clinical History. The patient is a. year-old woman with palpable lesion in the left upper inner quadrant. She now. Working Draft. undergoes partial mastectomy. Gross Description. The specimen Is received fresh in three parts, each labeled with the patient's name and medical record. number. Part A, additionally labeled. consists of one piece of pink-yellow,. fatty tissue measuring 2 x 1.4 x 0.7 cm. The specimen is trimmed, and one candidate lymph node is. found, inked green and bisected, entirely submitted for frozen section diagnosis 1, and subsequently. submitted in cassette A1. The remaining yellow, fatty tissue is entirely submitted in cassette A2. Part B, additionally labeled. consists of one soft, tan-yellow,. fatty tissue fragment measuring 3 x 1.5 x 0.5 cm. The specimen is trimmed, and one candidate. lymph node is entirely submitted for frozen section diagnosis 2, and subsequently submitted in. cassette B1. The remaining yellow, fatty tissue is entirely submitted in cassette B2. Part C is additionally labeled. It consists of. a yellow-white, fatty mastectomy specimen, measuring 3 (anterior to posterior) x 4.9 (medial to. lateral) x 6.2 (superior to inferior) cm and weighing 21.3 gm. There is a yellow-white, firm, irregular. mass, measuring 2 (anterior to posterior) x 2.1 (inferior to superior) x 1.5 (medial to lateral) cm, with. a central stellate appearance abutting the anterior-superior and posterior margins; it is 1.5 cm from. the anterior-inferior margin and 1 cm from the lateral and medial margins. The specimen is inked for. microscopic diagnosis so as the anterior-superior surface is blue, the anterior-inferior surface is green,. and the posterior surface is black. A portion of the tumor is taken for tissue banking. The specimen is. serially sectioned into seven 0.5-cm slices, from lateral to medial, and representative sections are. submitted as follows: Cassette C1: Representative section of slice 1, lateral margin, perpendicular. Cassette C2: Slice 2, superior portion. Cassette C3: Slice 2, inferior portion. Cassettes C4-C6: Tumor, slice 3, three pieces, superior to inferior. Cassettes C7-C8: Tumor, slice 4, two pieces, superior to Inferior. Cassettes C9-C10: Tumor, slice 5, two pieces, superior to inferior. Cassette C11: Slice 6. Cassettes C12-C13: Slice 7, medial margin, perpendicular. /Pathology Resident. /Pathologist. Signed: : Fee Codes: Other Specimens. Specimen Class: Accessioned: Specimen(s) Received: Cervical/Endocervical, Direct. Final Diagnosis. Cervical/Endocervical, Direct. NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNANCY. Atrophic pattern. SPECIMEN ADEQUACY: Satisfactory for evaluation. Transformation zone components are present. Working Draft. Specimen Class: Accessioned: Specimen(s) Received: Peritoneal Washing. Final Diagnosis. Peritoneal Washing. BENIGN. Reactive mesothelial cells. Specimen Class: Accessioned: Specimen(s) Received: A: Right ovary and tube (fresh), B: Left ovary and tube (fresh). Final Diagnosis. A. Right ovary and fallopian tube, risk-reducing salpingo-oophorectomy: - Ovary: Serosal calcifications, benign epithelial inclusion glands, adhesions and. endosalpingiosis. - Fallopian tube: No significant pathologic abnormality. B. Left ovary and fallopian tube, risk-reducing salpingo-oophorectomy: - Ovary: Serosal calcifications, benign epithelial inclusion glands, adhesions and. endosalpingiosis. - Fallopian tube: No significant pathologic abnormality. QA Review(s). Immuno. Problem? N. Reviewers: Result(s): Informed Pathologist (Name): Resolution(s): Repeat extra slides available: repeat and make up p53. Reason(s): Immuno Stain . No Staining: no stain in p53 control. related specimen(s): Specimen Class: Accessioned. Specimen(s) Received: right breast capsule. Final Diagnosis. Right breast, periprosthetic capsulectomy: Organizing granulation tissue. MD. MD. Specimen Class: Accessioned. Specimen(s) Received: Rectum, biopsy. Final Diagnosis. Rectum, biopsy: Focal cryptitis; see comment. Working Draft. Specimen Class: Accessioned: Specimen(s) Received: A: Left Breast, B: Left Nipple Aerolar Margin, C: Right Breast, D: Right Breast Aerolar Margin. Final Diagnosis. A. Left breast, mastectomy: 1. Intraductal papilloma (A10). 2. Breast with previous treatment effect. B. Left nipple areola margin, excision: Subareolar tissue with lactiferous ducts, no. carcinoma. C. Right breast, mastectomy: 1. Atypical lobular hyperplasia. 2. Breast with previous treatment effect. D. Right breast, areola margin, excision: Apocrine metaplasia, no carcinoma. pecimen Class: Accessioned: Specimen(s) Received: Cervical, Thin Prep Imaged. Final Diagnosis. Cervical, Thin Prep Imaged. NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNANCY. SPECIMEN ADEQUACY: Satisfactory for evaluation. Transformation zone components are present. Specimen Class: Accessioned: Specimen(s) Received: Left Breast, Fine Needle Aspiration. Final Diagnosis. Left Breast, Fine Needle Aspiration: Adenocarcinoma (see comment). Specimen Class: Accessioned. Specimen(s) Received: Vaginal/Cervical/Endocervical, Direct. Final Diagnosis. Vaginal/Cervical/Endocervical, Direct. CELLULAR CHANGES WITHIN NORMAL LIMITS. Working Draft. SPECIMEN ADEQUACY: Satisfactory for evaluation. Endocervical cells present. Specimen Class: Accessioned. Specimen(s) Received: A) POC. Final Diagnosis. UTERINE CONTENTS, ABORTION: IMMATURE PLACENTAL VILLI AND DECIDUA, CONSISTENT WITH. PRODUCTS OF CONCEPTION. Conversion. MD. FNN OF REPORT.

expanded version (tokens=2907) : 
 Histological Classification:
- Invasive Ductal Carcinoma
- Ductal Carcinoma In Situ, Solid and Micropapillary Types
- Lobular Carcinoma In Situ, Classic Type
- Atypical Ductal Hyperplasia involving Fibroadenoma

Subtype: LumA

Nuclear Grade: 2

Lymphovascular Invasion: Present

Calcification: None

Receptor Status:
- ER: Negative
- PR: Positive
- HER2/neu: Indeterminate (staining intensity score of 2)

Ancillary Testing Results:
- Immunohistochemistry for E-cadherin: Negative
- FISH testing for HER2/neu oncoprotein over-expression: Pending

Other findings:
- Necrosis in DCIS: Comedonecrosis, focal (<1/3)
- Lobular Carcinoma In Situ (LCIS): Present, classic small cell type
- Resection margins: Negative for invasive tumor and ductal carcinoma in situ
- AJCC/UICC stage: pT2N0(S)MX

Comments:
- Tumor infiltrating lymphocytes not mentioned in report
- No mention of any other special stains or ancillary testing performed besides those mentioned in the report.

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=3083) : 
 Invasive ductal carcinoma (LumA subtype) with ductal carcinoma in situ and lobular carcinoma in situ, classic type present. Nuclear Grade 2 with lymphovascular invasion but negative calcification. ER-negative, PR-positive, HER2/neu indeterminate. FISH testing pending. Comedonecrosis noted in DCIS. Resection margins negative for tumor involvement. AJCC/UICC stage pT2N0(S)MX confirmed. No tumor infiltrating lymphocytes mentioned nor references to any additional ancillary testing performed. Atypical ductal hyperplasia identified in fibroadenoma as an incidental finding.

